Novelty Technology Care Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 106

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 3

  • Investments
  • 4

Novelty Technology Care General Information

Description

Manufacturer of pharmaceutical products, medical devices and food supplements based in Milan, Italy. The company is engaged in the research, development and production of drugs, innovative medical devices and high-quality food supplements that are sold worldwide through licensees and distributors and is involved in the development of products in ophthalmology, gastroenterology and women's health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Via Dei Gracchi, 35
  • 20146 Milan
  • Italy
+39 02
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Food Products
Vertical(s)
Corporate Office
  • Via Dei Gracchi, 35
  • 20146 Milan
  • Italy
+39 02

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novelty Technology Care Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novelty Technology Care‘s full profile, request access.

Request a free trial

Novelty Technology Care Patents

Novelty Technology Care Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3228374-A1 Compound in the form of particles functionalized with high percentage ionic metal, and its use as an antimicrobial Pending 31-Aug-2021
EP-4396192-A1 Compound in the form of particles functionalized with high percentage ionic metal, and its use as an antimicrobial Pending 31-Aug-2021
EP-4240364-A1 Ophthalmic composition containing levofloxacin and ketorolac, method for the preparation and use thereof Pending 09-Nov-2020
CA-3197797-A1 Ophthalmic composition containing levofloxacin and ketorolac, method for the preparation and use thereof Pending 09-Nov-2020
AU-2021375352-A1 Ophthalmic composition containing levofloxacin and ketorolac, method for the preparation and use thereof Pending 09-Nov-2020 A61P27/02
To view Novelty Technology Care’s complete patent history, request access »

Novelty Technology Care Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novelty Technology Care Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novelty Technology Care‘s full profile, request access.

Request a free trial

Novelty Technology Care Investments (4)

Novelty Technology Care’s most recent deal was a Corporate Asset Purchase with NMTech (TiAb and SIAB Based Technology). The deal was made on 12-Jun-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NMTech (TiAb and SIAB Based Technology) 12-Jun-2019 Corporate Asset Purchase Buildings and Property
NMTech UK (TiAb and SIAB Technologies) 12-Jun-2019 Buyout/LBO Buildings and Property
Novartis (Portfolio of Ophthalmic Antibiotics) 31-May-2018 Buyout/LBO Buildings and Property
PH&T 01-Jan-2016 Buyout/LBO Pharmaceuticals
To view Novelty Technology Care’s complete investments history, request access »

Novelty Technology Care FAQs

  • When was Novelty Technology Care founded?

    Novelty Technology Care was founded in 2014.

  • Where is Novelty Technology Care headquartered?

    Novelty Technology Care is headquartered in Milan, Italy.

  • What is the size of Novelty Technology Care?

    Novelty Technology Care has 106 total employees.

  • What industry is Novelty Technology Care in?

    Novelty Technology Care’s primary industry is Pharmaceuticals.

  • Is Novelty Technology Care a private or public company?

    Novelty Technology Care is a Private company.

  • What is Novelty Technology Care’s current revenue?

    The current revenue for Novelty Technology Care is .

  • How much funding has Novelty Technology Care raised over time?

    Novelty Technology Care has raised $16.2M.

  • Who are Novelty Technology Care’s investors?

    Unigestion, Medeor Associates, and Wise Equity have invested in Novelty Technology Care.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »